Drug manufacturers such as Eli Lilly and Company have learned that medications like Mounjaro which were originally developed for other purposes, such as helping Type II diabetics balance their blood sugar levels, can become extremely profitable if they can also help patients lose weight. Unfortunately, diabetes medications like Mounjaro have been increasingly linked to gastroparesis and other digestive issues.
Eli Lilly, the manufacturer of Mounjaro, joins Ozempic manufacturer Novo Nordisk in legal turmoil over failing to disclose these risks. At Dolman Law Group, we are laying the groundwork to bring product liability lawsuits against negligent pharmaceutical companies on behalf of our injured clients. We encourage you to schedule a free consultation with our experienced team to discuss your Mounjaro lawsuit by calling us at (727) 451-6900 or completing our online contact form today.
The Mounjaro Stomach Paralysis Attorneys of Dolman Law Group Can Offer Exceptional Legal Guidance
One of the most critical decisions you will make about your product liability claim is which personal injury attorney you hire. The product liability lawyers of Dolman Law Group have cultivated a nationwide client base founded on our considerable resources, high standards for service, and ability to maximize compensation for our clients. We are the relentless team you need to establish liability and negotiate a fair settlement for your Mounjaro stomach paralysis lawsuit.
Over the past decade, the mass tort attorneys of Dolman Law Group have been at the forefront of the effort to assist consumers with seeking justice from negligent major pharmaceutical companies like Eli Lilly by pursuing product liability lawsuits to help clients recover compensation for their damages. This includes prominent issues like the Tepezza hearing loss claims and the Zantac cancer lawsuits. Our team is also currently involved in representing clients in the Ozempic stomach paralysis lawsuits. We have secured millions of dollars in compensation for clients to offset the harm done to their careers, health, and finances.
At Dolman Law Group, we firmly believe that every client’s experience matters, and we will provide your product liability lawsuit with the attention it deserves. Our award-winning personal injury attorneys are recognized for their record of success and high rates of client satisfaction, which is a point of pride for our team. Mounjaro users who have suffered the extensive financial and emotional costs of stomach paralysis can benefit from our years of experience and detail-oriented approach.
Mounjaro Users Say the Medication Has Alarming Side Effects Including Stomach Paralysis
Recent product liability lawsuits claim that Eli Lilly and other drug manufacturers like Novo Nordisk have negligently excluded the full range of possible complications from their product’s warning labels, leaving unwitting patients susceptible to serious injuries like stomach paralysis. Specifically, Mounjaro users have complained of gastroparesis, in addition to the minor side effects listed on the product, such as nausea.
Medications like Mounjaro work to help Type II diabetics deal with excess sugar in their blood. In addition to bolstering insulin production, Mounjaro slows the progression of food through the stomach to the small intestine. This becomes problematic when the slower speed impairs the digestive process to the point that the food can’t move to the next stage. Gastroparesis, also known as stomach paralysis, refers to a condition where the food is stuck in the stomach for a prolonged period of time.
Symptoms of gastroparesis include:
- Vomiting and nausea
- Loss of appetite or feeling full for a long time
- Dyspepsia, also known as indigestion
- Pain or discomfort
Over time, gastroparesis can lead to adverse health outcomes. For example, if you constantly feel full, you may not consume enough food to obtain the water and nutrients your body needs, which may turn into dehydration and malnutrition. Another concern is damage to the teeth and esophagus caused by corrosive stomach acid, which can happen if the patient is experiencing vomiting or acid reflux.
Ironically, gastroparesis can also create issues with blood sugar levels, which is what Mounjaro is supposed to address. In extreme cases of gastroparesis, surgical intervention may be necessary if the food has hardened to the point where it cannot be digested normally.
How Mounjaro’s Active Ingredients Cause Stomach Paralysis
Like Ozempic, Mounjaro is considered a glucagon-like peptide-1 (GLP-1) receptor agonist medication. When a drug has an agonist component, that means that element replaces the hormone that the patient is missing. In the case of Mounjaro, the Semaglutide portion of the medication fulfills the role of a Type II diabetic’s GLP-1 hormone, which would typically increase insulin production and limit glucagon. GLP-1 drugs can also restrain the gastric emptying stage of digestion.
Although Mounjaro manufacturers are facing similar criticisms as the makers of fellow Type II diabetes drug Ozempic, Mounjaro is not exclusively a Semaglutide-based medication. Mounjaro relies on Tirzepatide, which is a GLP-1 receptor agonist, as well as a glucose-dependent insulinotropic polypeptide (GIP) agonist. When acting as a GIP, Mounjaro is able to further increase insulin output to control high blood sugar levels.
Mounjaro’s multifaceted approach means that Type II diabetics may consume less food, contributing less sugar to the body, which is better equipped to process the sugar it does receive. The issue with Mounjaro and similar medications is that in delaying emptying stomach contents, the nerves that signal stomach muscles to contract can be compromised, leading to stomach paralysis. As a result, the food that is being digested becomes trapped because there is not enough momentum in the process to send the materials to the small intestine.
Plaintiffs Claim Mounjaro Manufacturer Did Not Accurately Describe Risks of Weight Loss Drug
Accurate warning labels on prescription medications are more important than ever as weight loss medications like Mounjaro are becoming increasingly accessible. Pharmaceutical manufacturer Eli Lilly has even created a telehealth website where patients can obtain prescriptions for Mounjaro remotely. As it stands, Mounjaro’s warning label does reference “delayed gastric emptying” as a potential side effect of using the Tirzepatide, though it does not specify gastroparesis as a possible complication.
One of the first plaintiffs in the Semaglutide stomach paralysis lawsuits, Jaclyn Bjorklund of Louisiana, has filed a claim alleging that Eli Lilly knew or should have been aware of the drug’s ability to cause stomach paralysis, and therefore had a legal duty to warn the public. For the company to be found liable, she must demonstrate that her gastroparesis and ensuing damages are the result of the drug manufacturer’s failure to correctly describe the risks of using their medication.
The pharmaceutical company argues that gastroparesis is often associated with Type II diabetes and should not be attributed to Mounjaro. While it is true that diabetes is a leading cause of gastroparesis, plaintiffs argue that does not explain cases where Mounjaro users experienced gastroparesis only after taking the medication, particularly for those who were not Type II diabetics. Both sides will hopefully have the opportunity to present their positions in court soon, as plaintiffs have requested that the Ozempic and Mounjaro stomach paralysis lawsuits be consolidated into a multidistrict litigation.
Product Liability Lawsuits Offer Plaintiffs the Opportunity for Compensation for Their Damages
The prospect of tapping into the multi-billion dollar weight loss market is tempting for many drug manufacturers, but it should not come at the price of patients’ physical and mental health, as well as financial stability. Mounjaro users are now seeking compensation for the costs they have incurred as a result of developing stomach paralysis in product liability lawsuits. Should they succeed in establishing Eli Lilly’s liability, plaintiffs may be able to recover compensation for damages such as:
- Medical bills, including dental work and surgery
- Lost wages
- Emotional distress
- Pain and suffering
- Loss of quality of life
- Cost of the medication
Healing from gastroparesis can be time-consuming, and you may suffer additional complications like an infection at the surgical site. As a result, you may need to delay returning to work or resuming your previous household responsibilities, exacerbating existing financial and logistical stressors.
It is common for plaintiffs to endure intangible losses as they navigate serious medical conditions like gastroparesis, such as a reduced quality of life after being hospitalized with a feeding tube to treat malnutrition related to their stomach paralysis. Both economic and non-economic damages are eligible for compensation in a Mounjaro stomach paralysis lawsuit.
Frequently Asked Questions About the Mounjaro Stomach Paralysis Lawsuits
What does it cost to hire a Mounjaro stomach paralysis attorney?
You can access the legal services of a personal injury attorney at no out-of-pocket cost. After your product liability lawyer has settled your Mounjaro stomach paralysis lawsuit, they recover a contingency fee sourced directly from your settlement. Typically, a contingency fee is about 33% of the final settlement, although courts can impose caps in certain situations. Their services are based on a percentage of the compensation they get you so if they do not settle your Mounjaro stomach paralysis claim you pay nothing.
Has the FDA approved Mounjaro for weight loss purposes?
Tirzepatide, which is marketed as Mounjaro, has been approved by the FDA to treat Type II diabetes in adults. The manufacturer of Mounjaro has also released Zepbound, a similar drug that received FDA approval for weight management in November 2023 for patients who are considered medically obese and also have a secondary health condition like Type II diabetes. Like Monjaro, Zepbound relies on Tirzepatide to reduce appetite by slowing the digestive process.
Is Mounjaro the same thing as Ozempic?
Ozempic and Mounjaro are both medications prescribed to treat Type II diabetes. Patients receive regular injections of the GLP-1 agonists that are intended to help balance blood sugar levels. The primary distinction between Ozempic and Mounjaro is that Ozempic is a brand name for a class of medications called Semaglutide, while Mounjaro is a Tirzepatide medication that also includes a glucose-dependent insulinotropic polypeptide component. Plaintiffs are also pursuing Ozempic stomach paralysis lawsuits based on similar allegations of negligence.
Why You Should Hire a Product Liability Lawyer to Represent Your Mounjaro Stomach Paralysis Claim
Injuries like gastroparesis can disrupt your daily life and your future financial stability. Choosing to file a product liability claim without the guidance of a qualified personal injury lawyer can jeopardize the compensation you need to offset these costs and create further stress. The parties evaluating the validity of your product liability claim are also more likely to consider your case seriously if you are represented by an established personal injury lawyer with a background in defective drug lawsuits.
Given the disputes over the precise cause of Mounjaro users’ gastroparesis, you should also decide to enlist the expertise of a product liability lawyer to not only accumulate reliable evidence of a causal relationship but also to assemble that evidence into a cohesive case. They have the staff and resources to accomplish this in a timely manner while overseeing the ongoing administrative side of filing a personal injury lawsuit, such as submitting requests for documents and scheduling depositions.
Furthermore, product liability lawyers have knowledge of the tactics defendants may employ to disenfranchise Mounjaro plaintiffs and how to protect the value of their client’s damages, resulting in better settlement outcomes. If you are suffering from gastroparesis related to Mounjaro, you should be able to make your health your priority, and a capable personal injury lawyer can allow you to do that by managing the details of your case.
Contact Dolman Law Group For Help With Your Mounjaro Stomach Paralysis Lawsuit
The defective drug lawyers of Dolman Law Group have been a respected name in personal injury law for the past decade, establishing ourselves as highly effective negotiators with a focus on client satisfaction. Our skilled team of Mounjaro stomach paralysis lawyers can offer you exceptional legal advice as you navigate the personal injury claims process to secure the compensation you deserve for your medical expenses, lost wages, and pain and suffering.
We encourage you to put your Mounjaro stomach paralysis lawsuit in the best position to recover maximum compensation by contacting the personal injury lawyers of Dolman Law Group at (727) 451-6900 or completing our online contact form to schedule a free consultation as soon as possible. Our team of product liability attorneys values your trust and will relentlessly seek a fair settlement for the damages you have sustained in your Mounjaro stomach paralysis lawsuit.